Fatty Liver Disease (MASLD): Symptoms, the New 2026 Treatments, and How to Check Your Liver From Home

If you have never worried about your liver, here is a number worth your attention. Fatty liver disease now affects roughly 4 in 10 American adults — the most common chronic liver condition in the country — yet most people who have it have no idea. It causes few or no symptoms until it is advanced, which is what makes it dangerous. The good news: in its early stages it is one of the most reversible chronic conditions in medicine, and 2024–2025 brought the first medications ever approved to treat it. Medical terms are explained as we go.

Quick Summary: Key Facts at a Glance

What Is Fatty Liver Disease — and Why Is It Now Called MASLD?

Your liver filters your blood, processes nutrients, and stores energy. In fatty liver disease, fat droplets accumulate inside liver cells — a state doctors call hepatic steatosis (steatosis means "fatty change"). A little fat is normal; when more than about 5% of the liver's weight is fat, it becomes a medical concern.

For decades this was called nonalcoholic fatty liver disease (NAFLD). In June 2023, a global panel of liver organizations led by the American Association for the Study of Liver Diseases (AASLD) retired that name. The new umbrella term is steatotic liver disease (SLD), and the most common type is metabolic dysfunction–associated steatotic liver disease (MASLD).

The change was not just cosmetic. The old name defined the disease by what it wasn't (not caused by alcohol); the new name defines it by what it is — a condition rooted in metabolic health. Under the 2023 definition, diagnosing MASLD requires liver fat plus at least one cardiometabolic risk factor — a heart-and-metabolism problem like extra weight or high blood sugar (full list below). A related category, MetALD, covers people with metabolic risk factors who also drink moderately; the advanced, inflamed form (previously "NASH") is now MASH.

If you were told years ago that you had "NAFLD," it is the same condition now called MASLD — no new diagnosis needed, just current information.

MASLD vs. MASH: What's the Difference?

MASLD is the broad condition — fat in the liver. MASH is a more advanced, inflamed stage. Only some people with MASLD progress to MASH, but MASH drives the serious liver damage.

The Spectrum: From Simple Fat to Serious Scarring

Think of fatty liver disease as a ladder — most people stay on the bottom rung, and a minority climb toward serious complications.

The key insight: the amount of scarring (fibrosis), not the amount of fat, predicts your future. That is why modern care focuses on finding fibrosis early — while it can still be slowed or reversed.

Symptoms: Why "Silent" Is the Whole Problem

Here is the hard truth: in most people, fatty liver disease produces no symptoms at all. It is frequently discovered by accident — on routine blood work showing mildly elevated liver enzymes, or on an ultrasound or CT scan ordered for something unrelated.

When symptoms do occur, they are vague and easy to dismiss — and the warning signs of advanced disease are more serious:

A fact most articles miss: for the average person with fatty liver disease, the greatest threat is not the liver — it is the heart. MASLD travels with the same problems that drive heart attacks and strokes, and cardiovascular disease is the leading cause of death in people with this condition. That is why your doctor watches your blood sugar, cholesterol, and blood pressure closely — treating the liver and the heart is one project.

Who's at Risk? The Five Cardiometabolic Factors (Plus a Surprise)

MASLD is diagnosed when liver fat is present alongside at least one of five cardiometabolic risk factors. Recognizing these in yourself is the single most useful thing you can do:

These overlap heavily with what is often called metabolic syndrome and with insulin resistance and prediabetes. The more boxes you check, the higher your risk.

The surprise — you don't have to be overweight. An often-missed form called lean MASLD occurs at a normal weight. Genetics play a role: a common variant in the PNPLA3 gene raises liver-fat risk and is notably more frequent in people of Hispanic ancestry — a meaningful point for our patients in Texas. If fatty liver runs in your family, a normal weight does not guarantee a healthy liver.

How Fatty Liver Disease Is Diagnosed — The FIB-4 Score You Should Know About

Because the disease is silent, the goal is not to wait for symptoms — it is to screen the right people. Guidelines, including practice guidance from AASLD, recommend a simple, stepwise approach any primary care doctor can start.

Step 1: The FIB-4 score

This is the most useful tool most patients have never heard of. The Fibrosis-4 (FIB-4) index is a free calculation from four values you likely already have: age, two liver enzymes (AST and ALT), and platelet count. Usually no new test is needed. Here's what it means:

(For adults 65+, doctors use a slightly higher low-risk cutoff of 2.0.)

Step 2: Elastography (a "FibroScan")

If your FIB-4 is in the middle zone, the next step is usually vibration-controlled transient elastography — a quick, painless ultrasound scan (a FibroScan) that measures liver stiffness, a stand-in for scarring. A liver biopsy, once routine, is now reserved for uncertain cases.

The advantage: Step 1 needs nothing more than a blood draw and a doctor to interpret it — exactly the kind of care telehealth is built for.

Treatment in 2026: Lifestyle First, and Now Real Medications

For years, doctors could only tell fatty-liver patients to "lose weight and eat better." That advice is still the foundation — but no longer all we have.

The cornerstone: weight loss, and how much you actually need

Weight loss remains the most effective treatment for MASLD, and the targets are clearer than most people realize:

You do not need to reach an "ideal" weight — even modest, sustained loss helps. A Mediterranean-style diet (vegetables, legumes, fish, olive oil, whole grains; limited red meat and added sugar) has the strongest evidence. Cutting sugary drinks and fructose matters most, and observational studies link 2–3 cups of coffee a day to less scarring. Aim for 150 minutes of moderate activity per week, and minimize alcohol.

For many patients, medically supervised weight loss, including GLP-1 medications, is what finally makes these targets achievable.

New in 2024–2025: the first FDA-approved liver drugs

For patients with MASH and moderate-to-advanced scarring, there are now prescription options where none existed:

Other GLP-1 medicines such as tirzepatide have shown strong MASH results in trials and are being studied for this use. Older options like vitamin E and pioglitazone are still used off-label in selected patients. These drugs are for confirmed, more advanced disease — which is why FIB-4 screening matters. Most people with simple fatty liver do best with lifestyle change and by treating their diabetes, cholesterol, and blood pressure. If you are not sure what your lipid panel is telling you, start with what your cholesterol numbers actually mean.

When to See Your Doctor — and How to Start From Home

Talk to a doctor about your liver if you have any of these: type 2 diabetes or prediabetes, a BMI of 25 or higher, high blood pressure, abnormal cholesterol or triglycerides, or "mildly elevated" liver enzymes on past blood work. You do not need symptoms — most people never get them.

This is a nearly ideal condition to evaluate through telehealth. From home, a board-certified physician can:

At Trinity Family Medicine, you see the same Texas-licensed, board-certified doctor at every visit, entirely online, with visits starting at $49.99 and no insurance required. If fatty liver disease is on your radar — or a lab or scan already flagged it — book online or call 817-932-4022.

Seek prompt care for the advanced warning signs listed earlier — jaundice, abdominal or leg swelling, vomiting blood, black stools, or confusion — which are not typical of early fatty liver disease and need urgent evaluation.

Frequently Asked Questions

Key Takeaways

The Bottom Line

Fatty liver disease is common, usually silent, and tied to weight, blood sugar, cholesterol, and blood pressure — so it threatens the heart as much as the liver. Caught early, it is highly treatable and often reversible. If you have any metabolic risk factor, don't wait for symptoms that may never come — ask a doctor for a simple FIB-4 score and find out where your liver stands.

References